Skip to main content

Hepatitis

Volume 486: debated on Monday 12 January 2009

To ask the Secretary of State for Health with reference to the answer to the hon. Member for Eddisbury of 6 October 2008, Official Report, columns 424-25W, on hepatitis, how many drugs were dispensed for the treatment of hepatitis B in each year since 1997 (a) for England in total, (b) in each strategic health authority area and (c) broken down by type of drug. (245646)

The following three tables show the number of prescription items dispensed in the community for the treatment of hepatitis B. The information is provided according to the individual British National Formulary (BNF) categories hepatitis B drugs fall within. Figures are split by strategic health authority (SHA) and presented in thousands. The data do not cover drugs dispensed in hospitals, including mental health trusts, or private prescriptions.

Due to the disclosive nature of the data, it was not possible to present the data by type of drug. As such, data were aggregated to BNF category to maintain some measure of difference between drug type. The SHA totals may not match the England total due to rounding.

BNF paragraph 8.2.4—Other immunomodulating drugs

Thousand

Number of prescription items used in the treatment of hepatitis B from BNF section 8.2.4, which were dispensed in the community in England from July 2003 to June 20081

SHA2,3

2003Jul-Dec

2004

2005

2006

2007

2008 Jan-Sep

East Midlands

0.1

0.1

0.1

0.1

0.1

4

East of England

0.1

0.2

0.2

0.1

0.1

0.1

London

0.1

0.2

0.2

0.2

0.2

0.1

North East

4

4

4

4

4

4

North West

0.2

0.2

0.3

0.2

0.2

0.2

South Central

0.1

0.1

0.2

0.1

0.1

0.1

South East Coast

0.2

0.3

0.2

0.1

0.1

0.1

South West

0.1

0.1

0.2

0.1

0.2

0.1

West Midlands

0.2

0.3

0.3

0.2

0.2

0.2

Yorkshire and the Humber

4

0.1

0.1

0.1

0.1

0.1

England

1.0

1.7

1.7

1.3

1.3

0.9

1 Information at SHA level is only available for the past 60 months.

2 The data have been structured in line with current SHA arrangements. The structure changed during 2006 where the number of SHAs reduced.

3 The tables show drugs which may be used to treat hepatitis B, by SHA.

4 Indicates 50 or fewer items were dispensed during the period.

Source:

The Prescription Pricing Division of the NHS Business Services Authority (NHSBSA (PPD))

BNF paragraph 5.3.3—Viral hepatitis

Thousand

Number of prescription items used in the treatment of hepatitis B from BNF section 5.3.3, which were dispensed in the community in England from July 2003 to June 20081

SHA2,3

2003 Jul-Dec

2004

2005

2006

2007

2008 Jan-Sep

East Midlands

4

4

4

4

0.1

0.1

East of England

4

4

0.1

4

0.1

0.2

London

0.1

0.1

0.2

0.5

0.6

0.5

North East

4

4

4

4

4

4

North West

4

4

4

4

0.1

0.1

South Central

4

4

4

4

0.1

0.1

South East Coast

4

4

0.1

0.1

0.1

0.1

South West

4

4

4

0.1

0.1

0.1

West Midlands

4

4

4

4

0.1

0.1

Yorkshire and the Humber

4

4

4

4

0.1

0.2

England

0.1

0.3

0.5

0.9

1.5

1.4

1 Information at SHA level is only available for the past 60 months.

2 The data have been structured in line with current SHA arrangements. The structure changed during 2006 where the number of SHAs reduced.

3 The tables show drugs which may be used to treat hepatitis B, by SHA.

4 Indicates 50 or fewer items were dispensed during the period.

Source

The Prescription Pricing Division of the NHS Business Services Authority (NHSBSA (PPD))

BNF paragraph 5.3.1—HIV infection

Thousand

Number of prescription items used in the treatment of hepatitis B from BNF section 5.3.1, which were dispensed in the community in England from July 2003 to June 20081

SHA2,3

2003 Jul-Dec

2004

2005

2006

2007

2008 Jan-Sep

East Midlands

0.1

0.2

0.2

0.3

0.4

0.3

East of England

0.2

0.4

0.5

0.6

0.8

0.7

London

0.7

1.7

1.9

2.4

3

2.3

North East

0.1

0.2

0.2

0.3

0.2

0.1

North West

0.3

0.5

0.5

0.6

0.7

0.6

South Central

0.1

0.2

0.2

0.3

0.3

0.3

South East Coast

0.1

0.2

0.3

0.4

0.4

0.4

South West

0.1

0.2

0.3

0.4

0.4

0.3

West Midlands

0.3

0.6

0.6

0.7

0.7

0.6

Yorkshire and the Humber

0.1

0.3

0.3

0.4

0.5

0.4

England

2.0

4.5

5.1

6.4

7.4

6.0

1 Information at SHA level is only available for the past 60 months.

2 The data have been structured in line with current SHA arrangements. The structure changed during 2006 where the number of SHAs reduced.

3 The tables show drugs which may be used to treat hepatitis B, by SHA.

Source:

The Prescription Pricing Division of the NHS Business Services Authority (NHSBSA (PPD))

To ask the Secretary of State for Health with reference to the answer to the hon. Member for Eddisbury of 6 October 2008, Official Report, column 422W, on hepatitis, how many notifications of hepatitis B have been made to the Health Protection Agency and its predecessor bodies in each year since 1997 (a) for England in total and (b) in each strategic health authority area; and what estimate he has made of the overall prevalence of hepatitis B in each strategic health authority area. (245647)

Data for notifications of hepatitis B by current and previous strategic health authorities (SHAs) are shown in the following table.

The Health Protection Agency Centre for Infections is not able to produce estimates of the prevalence of hepatitis B at SHA level.

Statutory notifications of hepatitis B in England by strategic health authority: 1997 to 2007

Strategic health authority

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

Current

Previous

East Midlands

Leicestershire, Northants., Rutland

21

22

33

33

17

28

24

28

36

77

65

Trent

8

25

20

35

26

35

28

16

32

26

28

East of England

Bedfordshire and Hertfordshire

15

13

24

38

48

66

51

59

59

14

8

Essex

6

4

3

7

8

6

3

3

3

Norfolk, Suffolk and Cambridgeshire

4

8

19

17

3

5

9

12

17

8

7

London

North Central London

30

55

37

39

30

27

44

27

16

24

28

North East London

30

30

57

50

43

36

18

23

10

20

11

North West London

10

13

14

27

19

13

21

11

8

11

8

South East London

87

87

101

92

149

162

157

174

209

171

111

South West London

12

16

13

11

9

14

5

8

6

7

8

North East

County Durham and Tees Valley

7

6

11

30

55

37

23

13

23

53

13

Northumberland, Tyne and Wear

24

20

14

16

15

31

80

70

91

30

20

North West

Cheshire and Merseyside

70

45

23

50

29

32

46

22

24

36

33

Cumbria and Lancashire

26

31

33

55

46

45

48

43

27

30

31

Greater Manchester

72

85

60

76

75

52

74

56

52

32

30

South Central

Hampshire and Isle of Wight

5

14

6

2

6

14

32

52

58

64

78

Thames Valley

18

21

30

32

28

34

17

13

35

30

138

South East Coast

Kent and Medway

6

23

16

27

37

20

25

23

28

10

18

Surrey and Sussex

48

37

34

51

40

27

14

24

34

26

39

South West

Avon, Gloucestershire and Wiltshire

4

2

12

10

20

80

60

50

55

69

86

Dorset and Somerset

20

45

22

51

57

42

43

72

71

45

52

South West Peninsula

2

14

17

16

14

5

5

7

10

8

3

West Midlands

Birmingham and the Black Country

18

21

25

21

14

35

33

100

109

56

45

Coventry, Warwicks., Herefords., Worcs.

9

8

5

7

5

14

22

12

10

10

32

Shropshire and Staffordshire

1

8

14

10

19

21

25

25

39

46

32

Yorkshire and Humberside

North and East Yorkshire , N Lincolnshire

53

100

116

77

68

55

85

64

63

58

81

South Yorkshire

15

5

13

16

28

29

38

60

36

26

47

West Yorkshire

49

54

45

89

62

48

67

70

81

71

68

Port Health Authority

1

1

Total

670

813

817

985

970

1,014

1,097

1,134

1,239

1,061

1,123

Notes:

1. Hepatitis B is notifiable under the Public Health (Infectious Diseases) Regulations 1988.

2. Strategic health authorities have been merged, and the number reduced from 28 to 10.

3. Cells are left empty if no cases have been reported.

4. These data have already been published.

Source:

Health Protection Agency